Launch week offerEnds in00h00m00s

annual Promonthly Pro

Antonella Tufano

Docenti di ruolo di IIa fascia

Università degli Studi di Napoli Federico II

Italy

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (12)

Remedios Otero-Candelera

Profesora asociada

Universidad de Sevilla

SPAIN

View details

Raffaele Pesavento

Professore Associato

University of Padova

ITALY

View details

Giuseppe Camporese

ITALY

View details

Danilo Menichelli

Sapienza University of Rome

ITALY

View details

Domenico Prisco

Full Professor

University of Florence

ITALY

View details

Alessandro Di Minno

University of Naples Federico II

ITALY

View details

Nicola Ferri

Docenti di ruolo di Ia fascia

University of Padova

ITALY

View details

Pablo Demelo-Rodríguez

Universidad Complutense de Madrid

SPAIN

View details

Juan José López Núñez

University of Barcelona

SPAIN

View details

JUAN-BOSCO LOPEZ-SAEZ

PROFESOR TITULAR DE UNIVERSIDAD

University Hospital

SPAIN

View details

Egidio Imbalzano

Associate Professor

University of Messina

ITALY

View details

Maria Donata Di Taranto

Associate professor of Clinical Biochemistry and Clinical Molecular Biology

Università degli Studi di Napoli Federico II Dipartimento di Medicina Molecolare e Biotecnologie Mediche

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Antonella Tufano

Research Interests

Make your next move.

Explore related searches

Articles (20)

Mesoglycan for long-term secondary prevention in patients with superficial vein thrombosis (METRO): a multicentre randomised clinical trial in Italy

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): An Immunopathogenic Model of Dysregulated Vaccine-Triggered Immunity

A Rare Case of Acquired Non-neutralizing Factor II Inhibitor in a Patient with B-Cell Lymphoproliferative Disorder.

Acquired Hemostasis Disorders.

Association between clinical frailty and multidrug-resistant positive cultures in hospitalized older adults.

Descriptive analysis of the Nationwide START2 antiphospholipid registry: Clinical and laboratory characteristics of patients with persistently positive antiphospholipid antibodies.

Emicizumab in Acquired Hemophilia A: A Real-World Case Series with Patient-Level Outcome Analysis

Hemostatic Aspects of Interactions Between Anticancer Drugs and Oral Anticoagulants in Patients with Cancer-Associated Venous Thromboembolism.

Heparin-induced thrombocytopenia: a challenging diagnosis in haemodialysis. State of art and review of the literature

Management of Inferior Vena Cava Thrombosis: Guidance from the Italian Society for the Study of Haemostasis and Thrombosis.

Real-world lipid outcomes after switching PCSK9-targeting therapies in heterozygous familial hypercholesterolemia: the SHIFT-FH study.

Thrombocytopenia in carriers and patients with antiphospholipid syndrome: insights from the nationwide START-APS registry.

Use of Plasma-Derived FVII Concentrate in Surgical Patients with Factor VII Deficiency: A Case Series.

Preferences Among Expert Physicians in Areas of Uncertainty in Venous Thromboembolism Management: Results from a Multiple-Choice Questionnaire

Baseline Hemoglobin Values and Clinical Outcomes in Acute Venous Thromboembolism: Insights From the RIETE Registry

A machine learning approach to identify patients at risk for long-term consequences after pulmonary embolism

Acquired Hemophilia A in a Case of Relapsed Immune Thrombotic Thrombocytopenic Purpura

Acute pulmonary embolism: a multimarker calculator to predict short-term outcomes.

Can LDL-C be too low? Time to rethink the "lower is better" paradigm

Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry

Collaborators (12)

Remedios Otero-Candelera

Raffaele Pesavento

Giuseppe Camporese

Danilo Menichelli

Domenico Prisco

Alessandro Di Minno

Nicola Ferri

Pablo Demelo-Rodríguez

Juan José López Núñez

JUAN-BOSCO LOPEZ-SAEZ

Egidio Imbalzano

Maria Donata Di Taranto

Make your next move.